where to give semaglutide shot Inject Ozempic: Stomach, Arm, or Thigh? how often do you take

A 2023 study of more than 17,000 patients published in the New England Journal of Medicine found that semaglutide reduced the risk of major cardiovascular events including heart attack, stroke and cardiovascular death by about 20% in overweight or obese adults who already have cardiovascular disease but not diabetes

In conclusion, GLP-1 receptor agonists are medications with a single mechanism of action, that is, they activate GLP-1 receptors at various organs, all of which contribute to weight loss

Research involving GIP agonism has explored its additive effects alongside GLP-1 signalling, with data suggesting complementary mechanisms that differ meaningfully from GLP-1 alone

Your provider will recommend the option that makes the most sense for your situation